መነሻ › ፎሊኩላር ሊምፎማ › Texas

በTexas ለፎሊኩላር ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለፎሊኩላር ሊምፎማ የሚደረጉ 35 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

NEXT Dallas, Irving
NEXT Oncology, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03460977

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Texas Children's Hospital, Houston

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Md Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05006716

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Texas Oncology - DFW (Sammons CC), Dallas
Baylor College of Medicine, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

University of Texas Southwestern, Dallas
MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07101328

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Baylor Scott & White Research Institute, Dallas
The University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT05765812

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site, Austin
Research Site, Lubbock
Research Site, Shenandoah
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06549595

NEO100 and High-Grade Meningioma

Baylor Scott and White, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT05023018

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, Austin
Research Site, Houston
Research Site, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06526793

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Texas Oncology, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ ከ12 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06784752

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Center for Oncology and Blood Disorders, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06091254

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06043323

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Research Site, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT07546760

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

M D Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT06108232

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

University of Texas Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
University of Texas Health Mays Cancer Center, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Baylor University Medical Center, Dallas
Texas Transplant Institute, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

University of Texas MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ13 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06533579

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

Natera, Inc., Austin

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07750886

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

The University of TX MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT07424833

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
The University of Texas Health Science at San Antonio, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁላይ 2026 · NCT05951777

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT05131022

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Texas Liver Institute - American Research Corporation, San Antonio
Pinnacle Clinical Research, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁን 2026 · NCT07559474

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Texas Oncology - Central/South Texas, Austin
Local Institution - 0212, Fort Worth
Local Institution - 0230, San Antonio
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ሜይ 2026 · NCT06911502

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ12 እስከ 95 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT04830137

Study of SGR-1505 in Mature B-Cell Neoplasms

University of Texas Southwestern, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT05544019

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

University of Texas Medical Branch at Galveston, TX, Galveston

ተሳታዮችን በመፈለግ ላይ

እድሜ 50 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ11 ፌብሩ 2026 · NCT07206121

Cognitive Screening Made Easy for PCPs - Administrative Supplement

Family Wellness Clinic, Austin
University of Texas Health Austin Primary Care Clinic, Austin
UT Health San Antonio's Geriatrics and Supportive Care Clinic, San Antonio

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ

እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ፌብሩ 2026 · NCT06928298

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Oncology Consultants, Houston
University of Texas MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ዲሴም 2025 · NCT05602363

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

SCRI, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኖቬም 2025 · NCT05643742

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Dallas
Massive Bio SYNERGY-AI site, Houston
Massive Bio SYNERGY-AI site, Temple

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

University of Texas Southwestern Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2025 · NCT05780034

Phosphatidylethanol and Other Ethanol Consumption Markers

University of North Texas, Denton
University of Texas Health Science Center San Antonio, San Antonio

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ

እድሜ 21 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2025 · NCT06747364

Paper-Based and Smartphone-Based Memory Supports

UT Health Austin Comprehensive Memory Center, Austin
Baylor Scott & White Healthcare, Temple
Baylor University, Waco

ተሳታዮችን በመፈለግ ላይ

እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2024 · NCT06444841

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።